Neurology® Podcast

In the first part of the podcast, Dr. Jason Crowell discusses the business of Alzheimer disease and how to approach teaching patients about aducanumab with Dr. Jason Karlawish. In the second segment, Dr. Jennifer Bickel talks with Dr. Eric Kaiser about the contribution of melanopsin and cone signals to light-induced reflexive eye closure in migraine.

In the first part of the podcast, Dr. Jason Crowell talks with Dr. Kiran Thakur about the importance of monitoring COVID-19 vaccines for neurologic adverse events and learning from past vaccination programs. In the second segment, Dr. Jeff Ratliff interviews Dr. Carles Gaig about the frequency and types of movement disorders in patients with anti-IgLON5 disease.

In the first part of the podcast, Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. In the second segment, Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.

In the first part of the podcast, Dr. Ted Burns interviews legendary musician Peter Frampton about his experience with inclusion body myositis and his storied career. For more with Peter Frampton, read the cover story in the October/November 2020 issue of Brain & Life, the AAN’s patient and caregiver magazine. In the second segment, Dr. Gordon Smith talks with Dr. Amy Tsou about the updated AAN Position Statement on ethical concerns raised by high drug costs.

The October 2021 replay of past episodes showcases a selection of interviews focused on thunderclap headache. This episode features Dr. Tesha Monteith in conversation with Dr. Andy Southerland and his patient, Martien Halvorson-Taylor, as well as with headache experts Drs. Jonathan Smith, Dileep Yavagal, and Alexandra Cocores.

In the first part of the podcast, Dr. Jeff Ratliff talks with Dr. Winston Chiong about the updated AAN Position Statement on Ethical Considerations in Dementia Diagnosis and Care. In the second segment, Dr. Gregg Day talks with Dr. Emily Edmonds about differing cognitive, biomarker, and neuropathologic trajectories in subtypes of mild cognitive impairment.

Dr. Alex Menze discusses the acute and chronic effects of a history of concussions with Dr. Nathan Churchill.

In the first part of the podcast, Dr. Stacey Clardy talks with Dr. Eoin Flanagan about how MRI T-2 lesion evolution differs across central nervous system demyelinating disorders. In the second segment, Dr. Teshamae Monteith talks with Dr. Gabriela Carvalho about behavioral and neuronal responses to a virtual roller coaster ride in patients with migraine.

In the first part of the podcast, Dr. Andy Southerland talks with Dr. Edward Chang about the use of a neuroprosthesis for decoding speech in a paralyzed person with anarthria. In the second segment, Dr. Jeff Ratliff discusses the trajectory and magnitude of the progression of clinical features in Lewy body dementia with Dr. Elie Matar.

The September 2021 replay of past episodes showcases a selection of interviews focused on the management of myasthenia gravis. The selected interviews feature Dr. Ted Burns and Dr. Stacey Clardy in conversation with Drs. Gil Wolfe, Joseph Shrager, and Pushpa Narayanaswami before closing with before closing with notes from Dr. Ted Burns on MuSK myasthenia gravis.

In the first segment, Dr. Matthew Barrett talks with Dr. Simone Baiardi about using real-time quaking-induced conversion (RT-QuIC) to identify patients with Lewy body disease. In the second part of the podcast, Dr. Jeff Ratliff discusses the association of central hypersomnia and fatigue in multiple sclerosis with Dr. Anne-Laure Dubessy.

In the first segment, Dr. Stacey Clardy talks with Dr. Daniel Hartung about whether closing the Part D coverage gap between 2010-2019 lowered patients’ out-of-pocket costs for multiple sclerosis drugs. In the second part of the podcast, Dr. Teshamae Monteith discusses sex, exercise, and other benign causes of thunderclap headache with Dr. Jonathan Smith in the final part of our four-part series on thunderclap headache.

In the first segment, Dr. Jason Crowell talks with Dr. Paul Ford about patient perceptions of the FDA approval process for disease modifying therapies in people living with multiple sclerosis. In the second part of the podcast, Dr. Teshamae Monteith discusses the management of cerebral aneurysm with Dr. Dileep Yavagal in the third part of our four-part series on thunderclap headache.

In the first segment, Dr. Halley Alexander talks with Dr. Pia De Stefano about the safety and efficacy of artificial coma induction in the treatment of status epilepticus. In the second part of the podcast, Dr. Teshamae Monteith discusses a case presentation of RCVS and clinical management with Dr. Andy Southerland and his patient, Martien Halvorson-Taylor, in the second part of our four-part series on thunderclap headache. Disclosures can be found at Neurology.org. CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.

In the first segment, Dr. Jon Stone talks with Dr. Anne Sofie Hansen about the spectrum and risk of psychiatric disorders in childhood-onset psychogenic nonepileptic seizures. In the second part of the podcast, Dr. Teshamae Monteith discusses ten causes of thunderclap headache and presentation with Dr. Alexandra Cocores in the first part of our four-part series on thunderclap headache. Disclosures can be found at Neurology.org. CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.

This month’s replay of past episodes showcases a selection of interviews concerning the FDA approval of aducanumab for the treatment of Alzheimer disease from clinical, political, and economic perspectives. The selected interviews feature conversations between Dr. Gregg Day and Pam Belluck, Dr. Jeff Burns and Dr. Ron Peterson, Dr. Jason Crowell and Dr. Steve Pearson, and Dr. Jeff Burns and Dr. Daniel Gibbs.

Dr. Stacey Clardy discusses the impact of surgical approaches to thymectomy upon remission rates in myasthenia gravis with Dr. Joseph Shrager.

In the first segment, Will Rondeau discusses the symptoms, incidence, and resource utilization of reversible cerebrovascular vasoconstriction syndrome with Dr. Jessica Magid-Bernstein. In the second part of the podcast, Dr. Andy Southerland discusses the optimization of atrial fibrillation treatment and stroke prevention with Dr. Seemant Chaturvedi.

In the first segment, Dr. Alex Menze talks with Dr. Clifford Saper about Havana Syndrome and recent attacks on American diplomats. In the second part of the podcast, Dr. Jeff Ratliff discusses the natural history of afferent baroreflex failure with Dr. Guillaume Lamotte.

In the first segment, Dr. Jeff Burns talks to neurologist Dr. Daniel Gibbs about his Alzheimer’s disease diagnosis and experience participating in a clinical trial for aducanumab. In the second part of the podcast, Dr. Gregg Day speaks with Dr. Josep Dalmau about NMDAR antibodies in patients with first episode psychosis and the utility of criteria for autoimmune psychosis.